SCHEMBL4880129

SCHEMBL4880129

COc1cccc(C2(C(=O)OS(N)(=O)=O)CCC(=Cc3ccccc3)CC2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 1/20 0.41
STS P08842 1/20 0.37
MIF P14174 1/20 0.37
ALDH1A1 P00352 3/20 0.37
MAOB P27338 2/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
BCHE P06276 1/20 0.37
PTGS2 P35354 1/20 0.36
EGFR P00533 1/20 0.36
OPRM1 P35372 1/20 0.36
OPRD1 P41143 1/20 0.36
OPRK1 P41145 1/20 0.36
OPRL1 P41146 1/20 0.36
NPC1 O15118 1/20 0.36
MAPT P10636 1/20 0.36
PKM P14618 1/20 0.36
RAB9A P51151 1/20 0.36
ATM Q13315 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4879932 0.87 SIGMAR1 (0.44) SIGMAR1ALDH1A1MAOBMEN1KMT2A
SCHEMBL4880472 0.84 STS (0.42) SIGMAR1STSALDH1A1
SCHEMBL4876712 0.82 OPRD1 (0.46) STSALDH1A1MEN1KMT2AOPRM1
SCHEMBL4880120 0.82 KMT2A (0.41) SIGMAR1MIFALDH1A1MAOBMEN1
SCHEMBL4880541 0.80 SOAT1 (0.48) ALDH1A1KMT2AOPRM1OPRD1OPRK1
SCHEMBL4880364 0.79 HDAC4 (0.41) STSALDH1A1OPRM1OPRD1OPRK1
SCHEMBL4877607 0.79 SIGMAR1 (0.42) SIGMAR1STSALDH1A1OPRD1OPRK1
SCHEMBL4878265 0.78 ALDH1A1 (0.43) STSALDH1A1MEN1KMT2AOPRM1
SCHEMBL4883886 0.77 L3MBTL1 (0.54) SIGMAR1ALDH1A1MEN1KMT2AOPRM1
SCHEMBL4877674 0.77 MEN1 (0.41) ALDH1A1MEN1KMT2ANPC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080096922-A1 Novel Sulfonamide derivative DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2008-04-24 US disclosed
EP-1736467-A1 NOVEL SULFONAMIDE DERIVATIVE Dainippon Sumitomo Pharma Co., Ltd. (JP) 2006-12-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080096922-A1 Novel Sulfonamide derivative NR4A1, NR4A2, NR4A3 SIGMAR1 298/4885STS 68/4885MIF 2049/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.